Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

被引:120
作者
Facchin, Sonia [1 ]
Vitulo, Nicola [2 ]
Calgaro, Matteo [2 ]
Buda, Andrea [1 ]
Romualdi, Chiara [3 ]
Pohl, Daniel [4 ]
Perini, Barbara [1 ]
Lorenzon, Greta [1 ]
Marinelli, Carla [1 ]
D'Inca, Renata [1 ]
Sturniolo, Giacomo Carlo [1 ]
Savarino, Edoardo Vincenzo [1 ]
机构
[1] Univ Hosp Padua, Dept Surg Oncol & Gastroenterol DISCOG, Via Giustiniani 2, Padua, Italy
[2] Univ Verona, Dept Biotechnol, Verona, Italy
[3] Univ Padua, Dept Biol, Padua, Italy
[4] Univ Hosp Zurich, Dept Gastroenterol, Zurich, Switzerland
关键词
16S metabarcoding; gut inflammation; inflammatory bowel disease; prebiotics; short-chain fatty acid; ULCERATIVE-COLITIS; FECAL MICROBIOTA; CROHNS-DISEASE; COLONIC-MUCOSA; CALPROTECTIN; BACTERIA; ENEMAS;
D O I
10.1111/nmo.13914
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Butyrate has shown anti-inflammatory and regenerative properties, providing symptomatic relief when orally supplemented in patients suffering from various colonic diseases. We investigated the effect of a colonic-delivery formulation of butyrate on the fecal microbiota of patients with inflammatory bowel diseases (IBDs). Methods In this double-blind, placebo-controlled, pilot study, 49 IBD patients (n = 19 Crohn's disease, CD and n = 30 ulcerative colitis, UC) were randomized to oral administration of microencapsulated-sodium-butyrate (BLM) or placebo for 2 months, in addition to conventional therapy. Eighteen healthy volunteers (HVs) were recruited to provide a healthy microbiota model of the local people. Fecal microbiota from stool samples was assessed by 16S sequencing. Clinical disease activity and quality of life (QoL) were evaluated before and after treatment. Key Results At baseline, HVs showed a different microbiota composition compared with IBD patients. Sodium-butyrate altered the gut microbiota of IBD patients by increasing bacteria able to produce SCFA in UC patients (Lachnospiraceae spp.) and the butyrogenic colonic bacteria in CD patients (Butyricicoccus). In UC patients, QoL was positively affected by treatment. Conclusions and Inferences Sodium-butyrate supplementation increases the growth of bacteria able to produce SCFA with potentially anti-inflammatory action. The clinical impact of this finding requires further investigation.
引用
收藏
页数:13
相关论文
共 52 条
  • [31] mixOmics: An R package for 'omics feature selection and multiple data integration
    Rohart, Florian
    Gautier, Benoit
    Singh, Amrit
    Le Cao, Kim-Anh
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (11)
  • [32] The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
    Satsangi, J.
    Silverberg, M. S.
    Vermeire, S.
    Colombel, J-F
    [J]. GUT, 2006, 55 (06) : 749 - 753
  • [33] EFFECT OF BUTYRATE ENEMAS ON THE COLONIC MUCOSA IN DISTAL ULCERATIVE-COLITIS
    SCHEPPACH, W
    SOMMER, H
    KIRCHNER, T
    PAGANELLI, GM
    BARTRAM, P
    CHRISTL, S
    RICHTER, F
    DUSEL, G
    KASPER, H
    [J]. GASTROENTEROLOGY, 1992, 103 (01) : 51 - 56
  • [34] The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease
    Sha, Sumei
    Xu, Bin
    Wang, Xin
    Zhang, Yongguo
    Wang, Honghong
    Kong, Xiangyun
    Zhu, Hongwu
    Wu, Kaichun
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 75 (03) : 245 - 251
  • [35] Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis
    Sivaprakasam, Sathish
    Bhutia, Yangzom D.
    Yang, Shengping
    Ganapathy, Vadivel
    [J]. COMPREHENSIVE PHYSIOLOGY, 2018, 8 (01) : 299 - 314
  • [36] Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
    Sokol, Harry
    Pigneur, Benedicte
    Watterlot, Laurie
    Lakhdari, Omar
    Bermudez-Humaran, Luis G.
    Gratadoux, Jean-Jacques
    Blugeon, Sebastien
    Bridonneau, Chantal
    Furet, Jean-Pierre
    Corthier, Gerard
    Grangette, Corinne
    Vasquez, Nadia
    Pochart, Philippe
    Trugnan, Germain
    Thomas, Ginette
    Blottiere, Herve M.
    Dore, Joeel
    Marteau, Philippe
    Seksik, Philippe
    Langella, Philippe
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (43) : 16731 - 16736
  • [37] Butyric acid: what is the future for this old substance?
    Sossai, Paolo
    [J]. SWISS MEDICAL WEEKLY, 2012, 142
  • [38] Colonization Resistance: Battle of the Bugs or Menage a Trois with the Host?
    Spees, Alanna M.
    Lopez, Christopher A.
    Kingsbury, Dawn D.
    Winter, Sebastian E.
    Baeumler, Andreas J.
    [J]. PLOS PATHOGENS, 2013, 9 (11)
  • [39] STEINHART AH, 1994, AM J GASTROENTEROL, V89, P179
  • [40] A look at the smelly side of physiology: transport of short chain fatty acids
    Stumpff, Friederike
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2018, 470 (04): : 571 - 598